ENDOMETRIAL ADENOCARCINOMA

This adverse event was reported 636 times

These drugs are most commonly taken by patients reporting ENDOMETRIAL ADENOCARCINOMA:

# Drug Count
0 METHOTREXATE SODIUM 60
1 LENALIDOMIDE 49
2 METHOTREXATE 47
3 LEVONORGESTREL 38
4 CYCLOPHOSPHAMIDE 34
5 CYCLOPHOSPHAMIDE FOR INJECTION 34
6 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 34
7 DOXORUBICIN 34
8 METFORMIN 34
9 METFORMIN ER 500 MG 32
See all common drugs associated with ENDOMETRIAL ADENOCARCINOMA

ENDOMETRIAL ADENOCARCINOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 IRON, FOLIC ACID, CYANOCOBALAMIN, ASCORBIC ACID, AND DOCUSATE SODIUM 1 0.0455
1 TOREMIFENE CITRATE 5 0.0116
2 SETMELANOTIDE 1 0.0035
3 L-ARGININE 1 0.0028
4 METEX 1 0.0026
5 DROSPIRENONE AND ESTRADIOL 1 0.0019
6 OSPEMIFENE 4 0.0015
7 BARICITINIB 4 0.0013
8 MECASERMIN 1 0.0012
9 ISATUXIMAB 7 0.0012
See all drugs enriched for association with ENDOMETRIAL ADENOCARCINOMA